Cancer Research UK

61 Lincoln's Inn Fields
London

WC2A 3PX
Telephone
020 7242 0200
Fax
020 7269 3100
Email
customer.services@cancer.org.uk, research_enquiries@cancer.org.uk
Charity Registration Number
225838
Year Established
2001
Trustees/Council of Management
Baroness Hayman (Chairman); David Newbigging (Deputy Chairman); Dr Keith Palmer (Treasurer); Prof Sir Leszek Borysiewicz; Prof Sir George Radda; Dr Philip Campbell; Prof. Nancy Rothwell; the Baroness Cumberlege; Sir John Skehel; Sir John Egan; Sir Kenneth Stowe; Prof Peter Goodfellow; Clive Strowger; Prof Keith Gull; Prof Jeffrey Tobias; Dame Bridget Ogilvie; Geoffrey van Cutsem; Dr Brendan O'Neill; Prof. the Lord Winston; Anthony H Percival.

Objects & Special Interests
Cancer Research UK supports cancer research in two complementary ways: by the award of grants to researchers in universities, medical schools and independent research institutes; and by the support of research in our own institutes and units where the staff are our employees. Cancer Research UK is committed to accelerating development of new treatments, refining diagnosis and improving the quality of life for cancer patients, and to playing its full role, working in partnership with others, to ensure that all prevention opportunities are taken.

Scientific Advisory Committee
Scientific Executive Board Prof. Alex Markham (Chair); Prof. Sir David Carter; Prof. Nick Day; Prof. Nick Hastie; Trevor Hince; Prof. Stanley Kaye; Prof. Tony Kouzarides; Harpal Kumar; Prof. Sir David Lane; Prof. Elizabeth Simpson; Prof. Robert Souhami; John Tooze; Richard Treisman; Prof. Karen Vousden

Disease Areas
Cancer

Types of Funding Schemes/Awards Available
Senior Clinical
Senior Non-Clinical
Junior Clinical
Junior Non-Clinical
Postgraduate
Project
Programme
Travel
Equipment
Biomedical Technology
Capital
therapy Research

Restrictions
UK only
Simultaneous Application CM

Additional Information on Restrictions
Travel and equipment grants are only available to those already in receipt of Cancer Research UK funding. Full details of Cancer Research UK funding schemes are available from our website.

Description of Peer Review Process
Applications are normally subject to external peer review. Feedback is provided to applicants whenever possible.

Research Strategy
To support the highest quality cancer research across a broad range of activities from understanding the nature of the cellular processes that, when disrupted, cause cells to become cancerous, through to the biology of cancer and its surrounding tisues, to the development and evaluation of new trearments, as well as diagnostic and preventative measures; extending to studies on the epidemiology of the disease and its psychosocial impact on sufferers, as well as studies on educational and communication about aspects of cancer. In all areas Cancer Research UK seeks to support research of the highest international standards and ensure that it is optimally funded. Intramural and extramural research is supported in institutes and university environments. We aim to foster interaction between our researchers and place emphasis on the translation of basic research findings to clinical evaluation and visa versa.

Collaborations
Board Membership of the National Cancer Research Institute (NCRI)

Expenditure on UK Medical Research
£257,132,000.0